252 related articles for article (PubMed ID: 8752809)
21. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass.
Lindpaintner K; Lee M; Larson MG; Rao VS; Pfeffer MA; Ordovas JM; Schaefer EJ; Wilson AF; Wilson PW; Vasan RS; Myers RH; Levy D
N Engl J Med; 1996 Apr; 334(16):1023-8. PubMed ID: 8598840
[TBL] [Abstract][Full Text] [Related]
22. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
[TBL] [Abstract][Full Text] [Related]
23. Influence of gene polymorphisms of the renin-angiotensin system on clinical outcome in heart failure among the Chinese.
Sanderson JE; Yu CM; Young RP; Shum IO; Wei S; Arumanayagam M; Woo KS
Am Heart J; 1999 Apr; 137(4 Pt 1):653-7. PubMed ID: 10097225
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction.
Palmer BR; Pilbrow AP; Yandle TG; Frampton CM; Richards AM; Nicholls MG; Cameron VA
J Am Coll Cardiol; 2003 Mar; 41(5):729-36. PubMed ID: 12628714
[TBL] [Abstract][Full Text] [Related]
25. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.
Schunkert H; Hense HW; Holmer SR; Stender M; Perz S; Keil U; Lorell BH; Riegger GA
N Engl J Med; 1994 Jun; 330(23):1634-8. PubMed ID: 8177269
[TBL] [Abstract][Full Text] [Related]
26. Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease.
Osono E; Kurihara S; Hayama N; Sakurai Y; Ohwada K; Onoda N; Takeuchi M; Tomizawa T; Komaba Y; Hashimoto K; Matsunobu S; Yoneshima H; Iino Y
Am J Kidney Dis; 1998 Nov; 32(5):725-30. PubMed ID: 9820440
[TBL] [Abstract][Full Text] [Related]
27. Progression of left ventricular hypertrophy and the angiotensin-converting enzyme gene polymorphism in hypertrophic cardiomyopathy.
Doolan G; Nguyen L; Chung J; Ingles J; Semsarian C
Int J Cardiol; 2004 Aug; 96(2):157-63. PubMed ID: 15314809
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
McNamara DM; Holubkov R; Janosko K; Palmer A; Wang JJ; MacGowan GA; Murali S; Rosenblum WD; London B; Feldman AM
Circulation; 2001 Mar; 103(12):1644-8. PubMed ID: 11273991
[TBL] [Abstract][Full Text] [Related]
29. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies.
Sasaki M; Oki T; Iuchi A; Tabata T; Yamada H; Manabe K; Fukuda K; Abe M; Ito S
J Hypertens; 1996 Dec; 14(12):1403-8. PubMed ID: 8986921
[TBL] [Abstract][Full Text] [Related]
30. Influence of cardiovascular risk factors on relation between angiotensin converting enzyme-gene polymorphism and blood pressure in arterial hypertension.
Celentano A; Mancini FP; Crivaro M; Palmieri V; De Stefano V; Ferrara LA; Di Minno G; de Simone G
J Hypertens; 1998 Jul; 16(7):985-91. PubMed ID: 9794739
[TBL] [Abstract][Full Text] [Related]
31. Deletion polymorphism of the angiotensin converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus.
Estacio RO; Jeffers BW; Havranek EP; Krick D; Raynolds M; Schrier RW
Am J Hypertens; 1999 Jun; 12(6):637-42. PubMed ID: 10371375
[TBL] [Abstract][Full Text] [Related]
32. Association of a deletion polymorphism of the angiotensin-converting enzyme gene with left-ventricular hypertrophy in Japanese women with essential hypertension; multicenter study of 1,919 subjects.
Kimura M; Yokota M; Fujimura T; Kato S; Hirayama H; Tsunekawa A; Maeda M; Inagaki H; Ogawa S; Nakashima N; Yamada Y
Cardiology; 1997; 88(4):309-14. PubMed ID: 9197423
[TBL] [Abstract][Full Text] [Related]
33. Effects of angiotensin-converting enzyme gene polymorphism on the left-ventricular function and mass in patients with acromegaly.
Erbas T; Alikasifoglu M; Aksöyek S; Unsal I; Gedik O; Tuncbilek E
Cardiology; 1999; 92(4):226-31. PubMed ID: 10844381
[TBL] [Abstract][Full Text] [Related]
34. Influence of angiotensinogen and angiotensin-converting enzyme polymorphisms on cardiac hypertrophy and improvement on maximal aerobic capacity caused by exercise training.
Alves GB; Oliveira EM; Alves CR; Rached HR; Mota GF; Pereira AC; Rondon MU; Hashimoto NY; Azevedo LF; Krieger JE; Negrão CE
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):487-92. PubMed ID: 19404196
[TBL] [Abstract][Full Text] [Related]
35. Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype.
Cicoira M; Zanolla L; Rossi A; Golia G; Franceschini L; Cabrini G; Bonizzato A; Graziani M; Anker SD; Coats AJ; Zardini P
J Am Coll Cardiol; 2001 Jun; 37(7):1808-12. PubMed ID: 11401115
[TBL] [Abstract][Full Text] [Related]
36. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
[TBL] [Abstract][Full Text] [Related]
38. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
Moleda P; Majkowska L; Kaliszczak R; Safranow K; Adler G; Goracy I
Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
[TBL] [Abstract][Full Text] [Related]
39. [I/D gene polymorphism of the angiotensin-converting enzyme and left ventricular hypertrophy. Response to converting enzyme inhibitors].
Rugale C; du Cailar G; Ribstein J; Mimran A
Arch Mal Coeur Vaiss; 2003; 96(7-8):772-5. PubMed ID: 12945221
[TBL] [Abstract][Full Text] [Related]
40. Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene and angiotensin-II type 1 receptor gene polymorphisms in patients with coronary artery disease.
Gruchala M; Ciećwierz D; Ochman K; Wasag B; Koprowski A; Wojtowicz A; Dubaniewicz W; Targoński R; Sobiczewski W; Grzybowski A; Romanowski P; Limon J; Rynkiewicz A
Clin Chem Lab Med; 2003 Apr; 41(4):522-8. PubMed ID: 12747597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
